drugset / Trial / NCT07119073

In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted)

NCT07119073

Phase 1 Completed 25 enrolled Cingulate Therapeutics
RandomizedCrossoverOpen-labelOther

Summary

The primary purpose of this study is to assess the effect of food on the rate and extent of absorption and the overall bioavailability of a single dose of CTx-1301 50 mg trimodal tablets in healthy adult volunteers.

Timeline

Start
2024-10-31
Primary completion
2024-12-21
Completion
2024-12-27

Drugs

EvaluationDrugModalityDoseRoute
Comparator dexmethylphenidate Unknown 50 mg

Indications

No indication recorded.